EDAP Announces FDA Clearance for Focal One

11:56 EDT 8 Jun 2018 | Investing News Network

EDAP (Nasdaq: EDAP) the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Focal One device for the ablation of prostate tissue. As quoted in the press release: The Focal One high intensity focused ultrasound (HIFU) device is the first medical … Continued

The post EDAP Announces FDA Clearance for Focal One appeared first on Investing News Network.

Original Article: EDAP Announces FDA Clearance for Focal One


More From BioPortfolio on "EDAP Announces FDA Clearance for Focal One"

Quick Search


Relevant Topics

Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...